• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    AstraZeneca Pharma India Limited — Important, 12-09-2025: Disclosure of material issue

    12-09-2025 | 02:37 pm

    AstraZeneca Pharma India (AZPIL) received a Show Cause Notice from the National Pharmaceutical Pricing Authority (NPPA). The issue: Alleged overcharging for 'Symbicort Turbuhaler' from April 2016 to July 2025, by selling above notified ceiling prices.

    Possible Impact: NPPA claims ~Rs. 60.50 Cr plus interest.

    Company Response: AZPIL strongly disputes this amount and has 30 days to submit its reply. The overall financial impact cannot be determined at this stage.

    #AZPIL #Pharma

    No comments yet. Be the first to comment!

    All announcements from AstraZeneca Pharma India Limited